Mebendazole for Stage 4 Colon Cancer
Mebendazole as Adjuvant Treatment for Colon Cancer
Recruiting
Phase 3
Interventional Study
Colorectal Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Sherief Abd-Elsalam · Other
Who this trial is looking for
This trial is looking for patients with stage 4 colorectal cancer to test a treatment called mebendazole. Participating means you will receive this medication as part of your cancer treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I have colorectal cancer stage 4.
You may not be able to join if
- I have agranulocytosis.
- I am pregnant.
- I am allergic to mebendazole.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
mebendazole treating colon cancer
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Colorectal cancer stage 4.
Exclusion Criteria:
* Agranulocytosis
* Pregnancy
* Allergy to mebendazole.
Contacts